These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10987606)

  • 1. Implantable defibrillators in the third millennium: increasingly relegated to a standby role?
    Saksena S
    J Am Coll Cardiol; 2000 Sep; 36(3):828-31. PubMed ID: 10987606
    [No Abstract]   [Full Text] [Related]  

  • 2. Filling the need for new antiarrhythmic drugs to prevent shocks from implantable cardioverter defibrillators.
    Curtis AB
    J Am Coll Cardiol; 2004 Jan; 43(1):44-6. PubMed ID: 14715181
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 4. Celivarone in patients with an implantable cardioverter-defibrillator: adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions.
    Gojkovic O; Aliot EM; Capucci A; Connolly SJ; Crijns H; Hohnloser SH; Kulakowski P; Roy D; Radzik D; Singh BN; Kowey PR
    Heart Rhythm; 2012 Feb; 9(2):217-224.e2. PubMed ID: 21978965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
    Hallstrom AP; McAnulty JH; Wilkoff BL; Follmann D; Raitt MH; Carlson MD; Gillis AM; Shih HT; Powell JL; Duff H; Halperin BD;
    J Am Coll Cardiol; 2001 Mar; 37(4):1093-9. PubMed ID: 11263614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-arrhythmic effects of statins: a hypothesis remains to be tested.
    Guo HM
    Heart Rhythm; 2008 Apr; 5(4):511-2. PubMed ID: 18362017
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
    Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials of implantable defibrillators.
    Myerburg RJ; Castellanos A
    N Engl J Med; 1997 Nov; 337(22):1621-3. PubMed ID: 9371860
    [No Abstract]   [Full Text] [Related]  

  • 9. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS.
    Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H
    Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.
    Cook JR; Rizo-Patron C; Curtis AB; Gillis AM; Bigger JT; Kutalek SP; Coromilas J; Hofer BI; Powell J; Hallstrom AP;
    Am Heart J; 2002 May; 143(5):821-6. PubMed ID: 12040343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic features of implantable cardioverters-defibrillators].
    Przybylski A; Zakrzewska-Koperska J
    Kardiol Pol; 2009 Mar; 67(3):310-6. PubMed ID: 19378240
    [No Abstract]   [Full Text] [Related]  

  • 15. The implantable defibrillator and antiarrhythmic drugs--competitive and complementary treatment for severe ventricular arrhythmia.
    Dorian P; Newman D
    Clin Cardiol; 1993 Nov; 16(11):827-30. PubMed ID: 8269662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary and secondary prevention of sudden cardiac death].
    Janion M; Sadowski M; Sielski J; Janion-Sadowska A
    Pol Arch Med Wewn; 2006 Jan; 115(1):65-72. PubMed ID: 17278788
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating antiarrhythmic drugs in implantable device.
    Saksena S
    J Interv Card Electrophysiol; 1998 Mar; 2(1):5-6. PubMed ID: 9869990
    [No Abstract]   [Full Text] [Related]  

  • 18. Recognition and management of cardiac arrhythmias.
    Chakko S; Kessler KM
    Curr Probl Cardiol; 1995 Feb; 20(2):53-117. PubMed ID: 7867372
    [No Abstract]   [Full Text] [Related]  

  • 19. Driving and ventricular arrhythmia: a historical perspective.
    Falk RH
    J Am Coll Cardiol; 2008 Jul; 52(4):316; author reply 317. PubMed ID: 18634990
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.